Early adoption patterns of the recombinant zoster vaccine: real-world versus clinical trial populations
Early RZV uptake in Denmark reached some high-risk individuals but also reflected socioeconomic disparities. Targeted outreach and continued monitoring of vaccine effectiveness in populations excluded from trials are needed to ensure equitable vaccine coverage.
Authors
- Morten Andersen (ORCID: https://orcid.org/0000-0001-7029-2860)
- Christine E. Hallgreen (ORCID: https://orcid.org/0000-0002-7916-3915)
- Débora Dalmas Gräf (ORCID: https://orcid.org/0000-0002-5900-540X)
- Dilsad Simay Peker (ORCID: https://orcid.org/0009-0007-1263-0658)
Institutions
- University of Copenhagen (DK)
Publication Details
- Journal
- Infectious Diseases
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1080/23744235.2025.2589360
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00